Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Parathyroid Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hyperparathyroidism, Primary 1

Interventions

Cisplatin 17Radiotherapy 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Fluorouracil 7Magnetic Resonance Spectroscopy 6Docetaxel 6Platinum 5Gemcitabine 51,2-diaminocyclohexaneplatinum II citrate 5Paclitaxel 4Specimen Handling 3Radiation 3Drug Therapy 3Cetuximab 3Carboplatin 3(225)Ac-DOTA-c(RGDyK) 3atezolizumab 2Iodine-123 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Disulfides 2Biopsy 2trametinib 1toripalimab 1ponatinib 1pertuzumab 1nimotuzumab 1fosbretabulin 1fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × fluorocholine × Head & Neck × Clear all
NCT07444723 2026-05-12

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡